ADMA Biologics
ADMA
ADMA
319 hedge funds and large institutions have $3.5B invested in ADMA Biologics in 2024 Q4 according to their latest regulatory filings, with 75 funds opening new positions, 124 increasing their positions, 103 reducing their positions, and 57 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
3.23% less ownership
Funds ownership: 89.53% → 86.29% (-3.2%)
16% less capital invested
Capital invested by funds: $4.16B → $3.5B (-$663M)
29% less funds holding in top 10
Funds holding in top 10: 7 → 5 (-2)
Holders
319
Holding in Top 10
5
Calls
$43.8M
Puts
$15.7M
Top Buyers
| 1 | +$62.3M | |
| 2 | +$46.9M | |
| 3 | +$32M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$21.5M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$17.4M |
Top Sellers
| 1 | -$52.6M | |
| 2 | -$49.4M | |
| 3 | -$37.7M | |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$35.3M |
| 5 |
AIC
AWM Investment Company
New York
|
-$34.8M |